Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic and immunologic features of recurrent stage I lung adenocarcinoma. | Sci Rep | 2021 | 34880292 | PubTator, text mining | PubMed |
| Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma. | Pharmgenomics Pers Med | 2021 | 34876833 | PubTator, text mining | PubMed |
| A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency. | mBio | 2021 | 34872356 | PubTator, text mining | PubMed |
| Monogenic Adult-Onset Inborn Errors of Immunity. | Front Immunol | 2021 | 34867986 | PubTator, text mining | PubMed |
| Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer. | J Exp Clin Cancer Res | 2021 | 34857028 | PubTator, text mining | PubMed |
| Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes. | Proc Natl Acad Sci U S A | 2021 | 34845035 | PubTator, text mining | PubMed |
| Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy. | Cell Rep Med | 2021 | 34841295 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies. | Cells | 2021 | 34831472 | PubTator, text mining | PubMed |
| Regenerating Damaged Myocardium: A Review of Stem-Cell Therapies for Heart Failure. | Cells | 2021 | 34831347 | PubTator, text mining | PubMed |
| Small Extracellular Vesicles in Transplant Rejection. | Cells | 2021 | 34831212 | PubTator, text mining | PubMed |
| Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions. | Cancers (Basel) | 2021 | 34830782 | PubTator, text mining | PubMed |
| What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1. | Int J Mol Sci | 2021 | 34830196 | PubTator, text mining | PubMed |
| An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes. | Biomedicines | 2021 | 34829842 | PubTator, text mining | PubMed |
| MOSES: A New Approach to Integrate Interactome Topology and Functional Features for Disease Gene Prediction. | Genes (Basel) | 2021 | 34828319 | PubTator, text mining | PubMed |
| Reversible phosphorylation of cyclin T1 promotes assembly and stability of P-TEFb. | Elife | 2021 | 34821217 | PubTator, text mining | PubMed |
| Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis. | Front Endocrinol (Lausanne) | 2021 | 34819919 | PubTator, text mining | PubMed |
| Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin's lymphoma. | Sci Rep | 2021 | 34819573 | PubTator, text mining | PubMed |
| Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes. | Front Immunol | 2021 | 34804019 | PubTator, text mining | PubMed |
| Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma. | Front Immunol | 2021 | 34795663 | PubTator, text mining | PubMed |
| Inclusion of a degron reduces levelsof undesired inteins after AAV-mediated proteintrans-splicing in the retina. | Mol Ther Methods Clin Dev | 2021 | 34786437 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=50